IL135303A0 - Tricyclic triazolobenzazepine derivatives, process for producing the same and antiallergic agents - Google Patents

Tricyclic triazolobenzazepine derivatives, process for producing the same and antiallergic agents

Info

Publication number
IL135303A0
IL135303A0 IL13530398A IL13530398A IL135303A0 IL 135303 A0 IL135303 A0 IL 135303A0 IL 13530398 A IL13530398 A IL 13530398A IL 13530398 A IL13530398 A IL 13530398A IL 135303 A0 IL135303 A0 IL 135303A0
Authority
IL
Israel
Prior art keywords
antiallergic agents
producing
same
alkyl
chem
Prior art date
Application number
IL13530398A
Other languages
English (en)
Original Assignee
Meiji Seika Kaisha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Seika Kaisha filed Critical Meiji Seika Kaisha
Publication of IL135303A0 publication Critical patent/IL135303A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/76Unsaturated compounds containing keto groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/738Esters of keto-carboxylic acids or aldehydo-carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/041,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IL13530398A 1997-09-29 1998-09-29 Tricyclic triazolobenzazepine derivatives, process for producing the same and antiallergic agents IL135303A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP26461197 1997-09-29
JP5206398 1998-03-04
PCT/JP1998/004363 WO1999016770A1 (fr) 1997-09-29 1998-09-29 Derives de triazolobenzazepine tricyclique, leur procede de production et antiallergique

Publications (1)

Publication Number Publication Date
IL135303A0 true IL135303A0 (en) 2001-05-20

Family

ID=26392670

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13530398A IL135303A0 (en) 1997-09-29 1998-09-29 Tricyclic triazolobenzazepine derivatives, process for producing the same and antiallergic agents

Country Status (25)

Country Link
US (3) US6372735B1 (de)
EP (1) EP1026167B1 (de)
JP (1) JP3188482B2 (de)
KR (1) KR100389140B1 (de)
CN (2) CN1312135C (de)
AT (1) ATE233764T1 (de)
AU (1) AU744636B2 (de)
BR (1) BR9814055B1 (de)
CA (1) CA2305307C (de)
DE (1) DE69811930T2 (de)
DK (1) DK1026167T3 (de)
ES (1) ES2191963T3 (de)
HK (1) HK1032782A1 (de)
HU (1) HUP0004020A3 (de)
ID (1) ID24101A (de)
IL (1) IL135303A0 (de)
NO (2) NO319542B1 (de)
NZ (1) NZ503601A (de)
PL (1) PL339544A1 (de)
PT (1) PT1026167E (de)
RU (1) RU2198885C2 (de)
SK (1) SK283869B6 (de)
TR (1) TR200000808T2 (de)
TW (1) TW510902B (de)
WO (1) WO1999016770A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE469902T1 (de) * 2001-12-26 2010-06-15 Meiji Seika Kaisha Amorphe substanz eines tricyclischen triazolobenzazepinderivats
ES2283781T3 (es) * 2002-02-01 2007-11-01 Meiji Seika Kaisha, Ltd. Procedimiento para producir un compuesto de 1,2,3-triazol.
WO2004004665A2 (en) 2002-07-09 2004-01-15 Bristol-Myers Squibb Company Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
ES2380319T3 (es) 2002-07-09 2012-05-10 Bristol-Myers Squibb Company Derivados heterocíclicos sustituidos útiles como agentes antidiabéticos y anti-obesidad y procedimiento
WO2004113343A1 (ja) * 2003-06-19 2004-12-29 Meiji Seika Kaisha, Ltd. 三環性トリアゾロベンゾアゼピン誘導体の新規結晶性物質
WO2004113424A1 (ja) * 2003-06-20 2004-12-29 Meiji Seika Kaisha, Ltd. 難水溶性物質と水溶性高分子との共沈物の製造方法
WO2005111039A2 (en) 2004-05-14 2005-11-24 Millennium Pharmaceuticals, Inc. Compounds and methods for inhibiting mitotic progression by inhibition of aurora kinase
JPWO2007100079A1 (ja) * 2006-03-02 2009-07-23 明治製菓株式会社 三環性トリアゾロベンゾアゼピン誘導体を含有する、アレルギー性眼疾患またはアレルギー性鼻疾患の予防または治療剤
JP5588172B2 (ja) * 2006-09-25 2014-09-10 フォルシュングフェアブント ベルリン エー.ファウ. プロリンが豊富なペプチドの構造的模倣薬およびその医薬用途
CL2007003244A1 (es) 2006-11-16 2008-04-04 Millennium Pharm Inc Compuestos derivados de pirimido[5,4-d][2]benzazepina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del cancer.
BRPI0821302A8 (pt) 2007-12-18 2015-12-08 Meiji Seika Kaisha Composição farmacêutica, método para prevenir ou tratar doenças do intestino inflamatórias, e, uso de um composto
ES2468391T3 (es) 2008-12-22 2014-06-16 Millennium Pharmaceuticals, Inc. Combinación de inhibidores de cinasas Aurora y anticuerpos anti-CD20
JO3635B1 (ar) 2009-05-18 2020-08-27 Millennium Pharm Inc مركبات صيدلانية صلبة وطرق لانتاجها
CA2804034C (en) 2010-01-07 2016-12-13 Laura Cook Blumberg Prodrugs of heteraromatic compounds
CN104031049A (zh) 2010-02-19 2014-09-10 米伦纽姆医药公司 极光激酶抑制剂的结晶形式
US20130303519A1 (en) 2012-03-20 2013-11-14 Millennium Pharmaceuticals, Inc. Methods of treating cancer using aurora kinase inhibitors
JP6360881B2 (ja) 2013-03-22 2018-07-18 ミレニアム ファーマシューティカルズ, インコーポレイテッドMillennium Pharmaceuticals, Inc. 触媒的mtorc1/2阻害薬及びオーロラaキナーゼの選択的阻害薬の組合せ

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5686442A (en) 1993-12-28 1997-11-11 Meiji Seika Kabushiki Kaisha Tricyclic benzazepine and benzothiazepine derivatives
WO1997000258A1 (fr) * 1995-06-15 1997-01-03 Meiji Seika Kabushiki Kaisha Composes de benzazepine tricyclique
TW486480B (en) * 1996-03-08 2002-05-11 Zeneca Ltd Azolobenzazepine derivatives and compositions and method of use thereof
US20070059533A1 (en) * 2005-09-12 2007-03-15 Burdette Steven R Thermal reflow of glass and fused silica body

Also Published As

Publication number Publication date
EP1026167A4 (de) 2001-07-11
ES2191963T3 (es) 2003-09-16
CN1155599C (zh) 2004-06-30
SK283869B6 (sk) 2004-03-02
AU744636B2 (en) 2002-02-28
HK1032782A1 (en) 2002-08-30
CN1523019A (zh) 2004-08-25
US20020137739A1 (en) 2002-09-26
DE69811930D1 (de) 2003-04-10
US7238812B2 (en) 2007-07-03
ID24101A (id) 2000-07-06
WO1999016770A1 (fr) 1999-04-08
NO20001500L (no) 2000-05-18
CA2305307C (en) 2004-11-30
ATE233764T1 (de) 2003-03-15
EP1026167A1 (de) 2000-08-09
US7022860B2 (en) 2006-04-04
RU2198885C2 (ru) 2003-02-20
US6372735B1 (en) 2002-04-16
BR9814055B1 (pt) 2009-05-05
HUP0004020A2 (hu) 2001-09-28
DE69811930T2 (de) 2003-12-18
NO319542B1 (no) 2005-08-29
BR9814055A (pt) 2000-09-26
JP3188482B2 (ja) 2001-07-16
NO20043765L (no) 2000-05-18
KR100389140B1 (ko) 2003-06-25
CA2305307A1 (en) 1999-04-08
CN1312135C (zh) 2007-04-25
PL339544A1 (en) 2000-12-18
NZ503601A (en) 2002-02-01
TW510902B (en) 2002-11-21
CN1278262A (zh) 2000-12-27
PT1026167E (pt) 2003-07-31
KR20010030784A (ko) 2001-04-16
DK1026167T3 (da) 2003-05-26
EP1026167B1 (de) 2003-03-05
HUP0004020A3 (en) 2002-12-28
US20060074074A1 (en) 2006-04-06
TR200000808T2 (tr) 2000-08-21
NO20001500D0 (no) 2000-03-23
AU9186998A (en) 1999-04-23
SK4252000A3 (en) 2000-10-09

Similar Documents

Publication Publication Date Title
IL135303A0 (en) Tricyclic triazolobenzazepine derivatives, process for producing the same and antiallergic agents
BE2018C008I2 (de)
DK1029853T3 (da) Heteroaromatiske bicykliske derivativer, der er egnede som anticancermidler
HUT63155A (en) Process for producing substituted taxane derivatives and pharmaceutical compositions comprising such compounds as active ingredient
HUT74182A (en) Novel imidazole derivatives, process for producing the same and pharmaceutical compositions containing the compounds
DK0928788T3 (da) Imidazolidin-4-on-derivater, der er nyttige som anticancer-midler
HK1019878A1 (en) Total synthesis of antitumor acylfulvenes.
CA2240927A1 (en) Process for production of piperidine derivatives
EP1110961A4 (de) Sauerstoffhaltige heterocyclische verbindungen
AU3415599A (en) Benzoheterocyclic distamycin derivatives, process for preparing them, and their use as antitumor agents
IL114785A0 (en) Pyrrolocarbazoles their preparation and pharmaceutical compositions containing them
NZ332923A (en) Distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents
EP1094055A4 (de) Neue vinylbenzolderivate
HUP0004413A2 (hu) 2-Aril-3-aroil-benzo[b]tiofének alkalmazása ösztrogén elvonási szindróma kezelésére alkalmas gyógyszerkészítmények előállítására
IE901314L (en) 2- substituted-n,n'-di(trimethoxybenzoyl)piperazines
HK1033455A1 (en) Novel tricyclic compounds, preparation method and pharmaceutical compositions containing same
EP1072582A4 (de) Intermediate in der synthese einer ringeinheit der in position 2 substituierten vitamin d derivate
EP0798304A4 (de) Medikamente gegen trhombocytopenie
EP1197211A4 (de) Wirkstoffe zur vorbeugung und behandlung von krebs
AR017971A1 (es) DERIVADOS TRICíCLICOS DE TRIAZOLBENZAZEPINAS, PROCEDIMIENTO PARA PRODUCIR LOS MISMOS, COMPOSICIONES FARMACEUTICAS FORMULADAS CON DICHOS COMPUESTOS Y COMPUESTOS INTERMEDIARIOS DE APLICACION EN DICHO PROCEDIMIENTO Y LA PEPARACION DE LOS MISMOS.
EP1251129A4 (de) Pyrimidinderivate mit antitumor-wirkung
EP0502488A3 (en) Phosphorus-containing azetidin-2-one derivatives